Fenebrutinib in PPMS: Insights from ACTRIMS Forum 2026

Fenebrutinib in PPMS: Insights from ACTRIMS Forum 2026

Clinical trial results unveiled today at ACTRIMS Forum 2026 suggest that fenebrutinib may be a novel and effective treatment option for people living with primary progressive multiple sclerosis. In this exclusive episode providing the first expert discussion of the complete dataset, FENtrepid trial leads Prof. Amit Bar-Or (University of Pennsylvania) and Dr. Stephen Hauser (University of California San Francisco) break down what the fenebrutinib results really show. Together, they explore:

  • Why BTK inhibition is uniquely positioned to address progressive MS biology
  • How fenebrutinib compared to ocrelizumab in the Phase 3 FENtrepid PPMS trial
  • What the data suggest for patients with non-relapsing, chronic disease

Listen for a deep dive into the science and the clinical implications.

Editorial Note:
At 21:49, the discussion refers to Müller cells. The correct term is Kupffer cells.

Download the transcript

--------------------------------

This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(84)

The Multi-Arm Multi-Stage Advantage: Transforming Multiple Sclerosis Trials

The Multi-Arm Multi-Stage Advantage: Transforming Multiple Sclerosis Trials

What if clinical trials could evaluate multiple treatment approaches at the same time and adapt as evidence emerges? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Jerem...

21 Sep 30min

The Blood–Brain Barrier in Multiple Sclerosis: From Dysfunction to Treatment

The Blood–Brain Barrier in Multiple Sclerosis: From Dysfunction to Treatment

The blood–brain barrier is a highly specialised interface that regulates the movement of cells, molecules and nutrients between the circulation and the central nervous system. But what happens when t...

10 Sep 25min

Predicting MS: Can Data Bring Us Closer to Personalised Care?

Predicting MS: Can Data Bring Us Closer to Personalised Care?

Can growing amounts of real-world MS data help clinicians predict disease progression and make more personalised treatment decisions? In this episode of the ECTRIMS Podcast, host Brett Drummond speak...

27 Aug 31min

How Technology Is Transforming Multiple Sclerosis Care

How Technology Is Transforming Multiple Sclerosis Care

Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of John...

12 Aug 31min

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Should High-Risk Populations Be Screened for Multiple Sclerosis?

Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration ...

30 Jul 32min

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

How Geography, Healthcare Systems and Access Shape the Multiple Sclerosis Journey

Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still f...

16 Jul 27min

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis

Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a sm...

2 Jul 23min

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation

Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond...

18 Jun 31min

Populært innen Vitenskap

fastlegen
romkapsel
liberal-halvtime
jss
tingenes-tilstand
forskningno
tomprat-med-gunnar-tjomlid
rekommandert
sinnsyn
villmarksliv
rss-paradigmepodden
fjellsportpodden
rss-nysgjerrige-norge
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
rss-rekommandert
tidlose-historier
nordnorsk-historie
rss-inn-til-kjernen-med-sunniva-rose
psykopoden
grunnstoffene